The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (35 analysts) rates it buy, with a mean price target of $1062.
Bajaj Finance
BAJFINANCE.NS · NSE
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 08:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price1,107.10 at the 13 Nov 2026 close
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-13).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Bajaj Finance holds its Markup at $1,107.10. Consolidating, no directional conviction, held for 5 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 5 days |
| Price at the screen | $1,107.10 |
| Valuation | 0.00 trailing · 0.00 forward price to earnings |
| Values screen | FAIL |
Five Screens, Shown in Full
Does not pass. Business activity exclusion: FAIL
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity exclusion: FAIL | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Bajaj Finance does not clear the screen at the business-activity stage. It operates in an area the screen excludes: Business activity exclusion: FAIL, so the financial ratios are not the deciding factor here.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BAJFINANCE.NS's ethical verdict changes
Today BAJFINANCE.NS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
| Forward P/E | 0.0x |
| Trailing P/E | 0.0x |
| Revenue growth | +0.0%revenue is shrinking |
| Profit margin | 0.0%currently unprofitable |
| Dividend yield | 0.59% |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBAJFINANCE.NS trades on NSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 9.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (35 analysts) rates it buy, with a mean price target of $1062.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (35 analysts) rates it buy, with a mean price target of $1062.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (35 analysts) rates it buy, with a mean price target of $1062.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 19.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (35 analysts) rates it buy, with a mean price target of $1062.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (35 analysts) rates it buy, with a mean price target of $1062.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (35 analysts) rates it buy, with a mean price target of $1062.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (35 analysts) rates it buy, with a mean price target of $1062.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-07 | BFL Employee Welfare Trust | Institution- Corporation | 7,025,731 | $27,859,131 | |
| 2025-12-29 | Bajaj (Sanjali) | Promoter | 1,488,436 | $16,507,648 | |
| 2025-12-29 | Bajaj (Siddhantnayan) | Promoter | 1,487,936 | $16,507,757 | |
| 2025-12-05 | Bajaj Allianz General Insurance Company Limited | Promoter | 191,000 | $2,243,256 | |
| 2025-09-29 | Bajaj Allianz General Insurance Company Limited | Promoter | 153,000 | $1,707,694 | |
| 2025-09-24 | Bajaj Allianz General Insurance Company Limited | Promoter | 529,000 | $6,145,287 | |
| 2025-06-13 | Bajaj (Kumud) | Promoter | 2,000 | $216,868 | |
| 2025-03-24 | Jain (Amisha) | UNREPORTED | 6,700 | $711,883 | |
| 2025-03-19 | Jain (Amisha) | UNREPORTED | 4,000 | $409,917 | |
| 2025-02-10 | Jain (Rajeev) | Director | 221,138 | $4,632,000 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
This entry now belongs to the ledger. Whatever BAJFINANCE.NS does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.